美股A股
StockGist
Back
10-K2026-02-20· deepseek-chat

MFA · MFA Financial, Inc.

0001055160-26-000004

SEC filing

Summary

MFA Financial, Inc. reported net income of $176.8 million for fiscal year 2025, with net income available to common stock of $136.5 million after preferred dividends of $40.3 million. The company generated $745.1 million in interest income, primarily from residential whole loans ($605.6 million) and securities ($121.3 million), offset by $514.0 million in interest expense. Net interest income was $231.1 million, and other income contributed $101.0 million, driven by a $133.7 million gain on residential whole loans measured at fair value. Operating expenses totaled $155.1 million. The balance sheet shows total assets of $13.05 billion, with residential whole loans ($8.81 billion) and securities ($3.36 billion) as major components. Total liabilities were $11.22 billion, resulting in stockholders' equity of $1.83 billion. Cash flow from operations was $76.2 million, while investing activities used $1.79 billion primarily for loan purchases and securities acquisitions. Financing activities provided $1.49 billion from net borrowings. The company paid $148.2 million in common stock dividends and $40.3 million in preferred stock dividends.

Key takeaways

Full analysis

Performance Summary

MFA Financial, Inc. reported net income of $176.8 million for fiscal year 2025, with income before taxes of $176.0 million. The company generated $745.1 million in interest income, primarily from residential whole loans ($605.6 million) and securities at fair value ($121.3 million). Interest expense totaled $514.0 million, resulting in net interest income of $231.1 million. After a $936,000 reversal for credit losses on residential whole loans, net interest income after credit provisions was $230.1 million. Other income contributed $101.0 million, largely from a $133.7 million gain on residential whole loans measured at fair value through earnings. Operating expenses of $155.1 million included compensation and benefits ($77.7 million), other general and administrative expense ($41.7 million), and loan servicing costs ($33.4 million). Net income available to common stock and participating securities was $136.5 million after deducting $40.3 million for preferred stock dividends. Basic and diluted earnings per common share were both $1.00.

Revenue Analysis

The company's revenue streams are concentrated in interest income from its investment portfolio. Residential whole loans generated $605.6 million in interest income, representing 81.2% of total interest income. Securities at fair value contributed $121.3 million (16.3%), while other interest-earning assets ($2.0 million) and cash equivalents ($16.2 million) provided the remainder. Other income of $101.0 million included significant gains from residential whole loans measured at fair value ($133.7 million) and Lima One mortgage banking income ($22.8 million), offset by losses on securities (-$61.5 million), derivatives (-$35.5 million), securitized debt (-$55.2 million), and real estate owned (-$6.8 million). The company's revenue model relies heavily on its residential mortgage loan portfolio and related investment activities.

Margins & Profitability

The company's net interest margin can be inferred from the relationship between interest-earning assets and liabilities, though specific margin percentages are not disclosed in the provided data. Operating expenses of $155.1 million represented 20.8% of total interest income. Compensation and benefits ($77.7 million) accounted for 50.1% of operating expenses, followed by other general and administrative expense ($41.7 million, 26.9%) and loan servicing costs ($33.4 million, 21.5%). The provision for income taxes showed a benefit of $735,000, resulting in an effective tax rate that cannot be calculated from the provided data. Profitability was supported by the $133.7 million gain on residential whole loans measured at fair value, which significantly contributed to the $101.0 million in other income.

Cash Flow & Balance Sheet

Cash flow from operations was $76.2 million, derived from net income of $176.8 million adjusted for non-cash items including net gain on residential whole loans ($138.8 million) and net margin received for derivatives ($96.1 million). Investing activities used $1.79 billion primarily for purchases and origination of residential whole loans ($2.69 billion) and purchases of securities ($2.16 billion), partially offset by principal payments on residential whole loans ($2.44 billion) and securities ($289.6 million). Financing activities provided $1.49 billion from net borrowings under financing agreements, offset by dividend payments of $188.5 million ($148.2 million common, $40.3 million preferred). The balance sheet shows total assets of $13.05 billion, with residential whole loans ($8.81 billion) and securities ($3.36 billion) comprising 93.3% of assets. Total liabilities of $11.22 billion include financing agreements of $10.94 billion, resulting in a debt-to-equity ratio of approximately 6.1:1. Stockholders' equity was $1.83 billion with an accumulated deficit of $1.90 billion.

Outlook

The filing does not contain explicit forward-looking statements, management guidance, or strategic priorities in the provided content. The company's performance appears dependent on its residential whole loan portfolio, which represents the majority of its assets and interest income. Risk factors inherent in the business model include interest rate sensitivity, credit risk on residential loans, and market valuation changes affecting securities and derivatives. The company's significant borrowing activities ($10.94 billion in financing agreements) indicate reliance on leverage to fund its investment portfolio. Dividend payments totaling $188.5 million suggest a commitment to returning capital to shareholders, though the sustainability of such payments depends on future earnings and cash flow generation. The absence of segment data suggests the company operates as a single business segment focused on residential mortgage investments.